Lymphoproliferative disorders of natural killer cells

International Journal of Hematology

Volumn 63, Issue 4, 1996, Pages 279-290

  Oshimi, Kazuo ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute leukemia of natural killer cell lineage; Natural killer cell lineage granular lymphocyte proliferative disorderes; Natural killer cells; Natural killer cell lymphoma

Indexed keywords

CD16 ANTIGEN; CD53 ANTIGEN; UNCLASSIFIED DRUG;

EPSTEIN BARR VIRUS; HUMAN; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; NATURAL KILLER CELL LEUKEMIA; NATURAL KILLER CELL LYMPHOMA; NOSE; PRIORITY JOURNAL; REVIEW;

EID: 0029989077     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-5710(96)00450-1     Document Type: Review

References (108)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
2. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990;76:2421-2438.
3. Rosenberg EB, McCoy JL, Green SS, et al. Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays. J Natl Cancer Inst 1974;52:345-352.
4. Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 1975;16:216-229.
5. Kiessling R, Klein E, Wigzell H. 'Natural' killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975;5:112-117.
6. Saksela E, Timonen T, Ranki A, Hayry R. Morphological and functional characterization of isolated effecter cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets. Immunol Rev 1979;44:71-123.
7. Lanier LL, Spits H, Phillips JH. The developmental relationship between NK cells and T cells. Immunol Today 1992;13:392-395.
8. Pollack SB. Production and differentiation of NK lineage cells in bone marrow. Nat Immun 1993;12:177-193.
9. Spits H, Lanier LL, Phillips JH. Development of human T and natural killer cells. Blood 1995;85:2654-2670.
10. Hercend T, Schmidt RE. Characteristics and uses of natural killer cells. Immunol Today 1988;9:291-293.
11. Phillips JH, Hori T, Nagler A, Bhat N, Spits H, Lanier LL. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3ε,δ proteins. J Exp Med 1992;175: 1055-1066.
12. Lanier LL, Chang C, Spits H, Phillips JH. Expression of cytoplasmic CD3ε proteins in activated human adult natural killer (NK) cells and CD3γ,δ,ε complexes in fetal NK cells. Implications for the relationship of NK and T lymphocytes. J Immunol 1992;149:1876-1880.
13. Nagler A, Lanier LL, Cwirla S, Phillips JH. Comparative studies of human FcRIII positive and negative natural killer cells. J Immunol 1989;143:3183-3191.
14. Alley CD, MacDermott RP. Investigation of the blastogenic and cytotoxic capabilities of human bone marrow: differences between aspirate and rib marrow. Blood 1980;55:669-676.
15. Oshimi K. Granular lymphocyte proliferative disorders: report of 12 cases and review of the literature. Leukemia 1988;2:617-627.
16. Oshimi K, Yamada O, Kaneko T, et al. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 1993;7: 782-788.
17. Semenzato G, Pandolfi F, Chisesi T, et al. The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer 1987;60:2971-2978.
18. Pandolfi F, Zambello R, Cafaro A, Semenzato G. Biologic and clinical heterogeneity of lymphoproliferative diseases of peripheral mature T lymphocytes. Lab Invest 1992;67:274-302.
19. Loughran TP, Starkebaum G. Large granular lymphocyte leukemia. Report of 38 cases and review of the literature. Medicine 1987;66:397-405.
20. Loughran TR Clonal diseases of large granular lymphocytes. Blood 1993;82:1-14.
21. Dhodapkar MV, Li C-Y, Lust JA, Tefferi A, Phyliky RL. Clinical spectrum of clonal proliferation of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood 1994;84:1620-1627.
22. Tefferi A, Li C-Y, Witzig TE, Dhodapkar MV, Okuno SH, Phyliky RL. Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood 1994;84:2721-2725.
23. Schiller GJ, Naeim F, Champlin RE. Bone marrow aplasia associated with proliferation of large granular lymphocytes and subsequent transformation to acute lymphoblastic leukemia. Am J Hematol 1989;32: 153-154.
24. Bassan R, Rambaldi A, Abbate M, et al. Association of NK-cell lymphoproliferative disease and nephrotic syndrome. Am J Clin Pathol 1990;94:334-338.
25. Koizumi S, Seki H, Tachinami T, et al. Malignant clonal expansion of large granular lymphocytes with a Leu-11+, Leu-7-surface phenotype: in vitro responsiveness of malignant cells to recombinant human interleukin 2. Blood 1986;68:1065-1073.
26. Fernandez LA, Pope B, Lee C, Zayed E. Aggressive natural killer cell leukemia in an adult with establishment of an NK cell line. Blood 1986;67:925-930.
27. Sheridan W, Winton EF, Chan WC, et al. Leukemia of non-T lineage natural killer cells. Blood 1988;72: 1701-1707.
28. Imamura N, Kusunoki Y, Kawa-Ha K, et al. Aggressive natural killer cell leukemia/lymphoma: report of four cases and review of the literature. Br J Haematol 1990;75:49-59.
29. Taniwaki M, Tagawa S, Nishigaki H, et al. Chromosomal abnormalities define clonal proliferation in CD3-large granular lymphocyte leukemia. Am J Hematol 1990;33:32-38.
30. Okuda T, Sakamoto S, Deguchi T, et al. Hemophagocytic syndrome associated with aggressive natural killer cell leukemia. Am J Hematol 1991;38:321-323.
31. Hart DNJ, Baker BW, Inglis MJ, et al. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 1992;79:2116-2123.
32. Gelb AB, van de Rijn M, Regula DP, et al. Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum Pathol 1994;25:953-960.
33. Shimodaira S, Ishida F, Kobayashi H, Mahbub B, Kawa-Ha K, Kitano K. The detection of clonal proliferation in granular lymphocyte-proliferative disorders of natural killer cell lineage. Br J Haematol 1995;90: 578-584.
34. Ohno T, Kanoh T, Arita Y, et al. Fulminant clonal expansion of large granular lymphocytes. Characterization of their morphology, phenotype, genotype, and function. Cancer 1988;62:1918-1927.
35. Ohno Y, Anakawa R, Fukuhara S, et al. Acute transformation of chronic large granular lymphocyte leukemia associated with additional chromosome abnormality. Cancer 1989;64:63-67.
36. Orman SV, Schechter GP, Whang-Peng J, et al. Nephrotic syndrome associated with a clonal T-cell leukemia of large granular lymphocytes with cytotoxic function. Arch Intern Med 1986;146:1827-1829.
37. Yamamoto T, Iwasaki T, Watanabe N, et al. Expression of multidrug resistance P glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorders. Blood 1993;81: 1342-1346.
38. Kawa-Ha K, Ishihara S, Ninomiya T, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989;84:51-55.
39. Loughran TP, Zambello R, Ashley R, et al. Failure to detect Epstein-Barr virus DNA in peripheral blood mononuclear cells of most patients with large granular lymphocyte leukemia. Blood 1993;81:2723-2727.
40. Kaneko T, Fukuda J, Yoshihara T, et al. Nasal natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells. Br J Haematol 1995;91:355-361.
41. Zambello R, Trentin L, Ciccone E, et al. Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes. Blood 1993;81:2381-2385.
42. Nash R, McSweeney P, Zambello R, Semenzato G, Loughran TP. Clonal studies of CD3-lymphoproliferative disease of granular lymphocytes. Blood 1 993;81:2363-2368.
43. Tefferi A, Greipp PR, Leibson PJ, Thibodeau SN. Demonstration of clonality, by X-linked DNA analysis, in chronic natural killer cell lymphocytosis and successful therapy with oral cyclophosphamide. Leukemia 1992; 6:477-480.
44. Pandolfi F, Pezzuito A, de Rossi G, et al. Characterization of two patients with lymphomas of large granular lymphocytes. Cancer 1984;53:445-452.
45. Watanabe S, Sato Y, Shimoyama M, Minato K, Shimosato Y. Immunoblastic lymphadenopathy, angio-immunoblastic lymphadenopathy, and IBL-like T-cell lymphoma. Cancer 1986;58:2224-2232.
46. Chan JK, Ng CS, Chu YC, Wong KF. S-100 protein-positive sinusoidal large cell lymphoma. Hum Pathol 1987;18:756-758.
47. Longacre TA, Listrom MB, Spigel JH, Willman CL, Dressler L, Clark D. Aggressive jejunal lymphoma of large granular lymphocytes. Am J Clin Pathol 1990;93:124-132.
48. Sun T, Schulman P, Kolitz J, et al. A study of lymphoma of large granular lymphocytes with modern modalities: report of two cases and review of the literature. Am J Hematol 1992;40:135-145.
49. Kurita S, Nakamura S, Yamamoto K, et al. Mediastinal diffuse large cell lymphoma of B-cell type with azurophilic granules. Int J Hematol 1 992;56:51-58.
50. Nakagawa A, Nakamura S, Koshikawa T, et al. Clinico-pathologic study of primary mediastinal non-lymphoblastic non-Hodgkin's lymphomas among the Japanese. Acta Pathol Jpn 1993;43:44-54.
51. Tsai T-F, Su I-J, Lu Y-C et al. Cutaneous angiocentric T-cell lymphoma associated with Epstein-Barr virus. J Am Acad Dermatol 1992;26:31-38.
52. Gong J-H, Maki G, Klingemann H-G. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 1994;8:652-658.
53. Sun T, Brody J, Susin M, et al. Aggressive natural killer cell lymphoma/leukemia. Am J Surg Pathol 1993; 17:1289-1299.
54. Wong KF, Chan JKC, Ng CS, Tsang WYW, Cheung MMC. CD56 (NKHl)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum Pathol 1992;23:798-804.
55. Nakamura S, Suchi T, Koshikawa T, et al. Aggressive rectal lymphoma of large granular lymphocytes with the histologic feature of an angiocentric growth pattern. Cancer 1993;71:249-256.
56. Ng GS, Ghan JK, Lo STH. Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum Pathol 1987;18:1257-1262.
57. Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992;79:2432-2437.
58. Shimoyama M, Minato K, Seki S, et al. Prognosis of non-Hodgkin's lymphoma. 1. T and B-lymphoma and its primary sites. Rinsho Ketsueki 1985;26:906-915.
59. Ho FCS, Todd D, Loke SL, et al. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period. Int J Cancer 1984;34:143-148.
60. Frierson HF Jr, Mills SE, Innes DJ Jr. Non-Hodgkin's lymphomas of the sinonasal region: histologic subtypes and their clinicopathologic features. Am J Clin Pathol 1984;81:721-727.
61. Chan JKC, Ng CS, Lau WH, Lo STH. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 1987;11:418-429.
62. Liang R, Todd D, Chan TW, et al. Nasal lymphoma. A retrospective analysis of 60 cases. Cancer 1990;66: 2205-2209.
63. Frierson HF, Innes DJ, Mills SE, Wick MR. Immunophenotypic analysis of sinonasal non-Hodgkin's lymphomas. Hum Pathol 1989;20:636-642.
64. Abbondanzo SL, Wenig BM. Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases. Cancer 1995;75: 1281-1291.
65. Arber DA, Weiss LM, Albujar PF, Chen YY, Jaffe ES. Nasal lymphomas in Peru, high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 1993;17:392-399.
66. Navarro-Roman L, Zarate-Osorno A, Meneses A, Kingma DW, Jaffe ES. High grade AIL and Epstein-Barr virus infection in 22 cases from Mexico. Mod Pathol 1994;7:117A.
67. Ferry JA, Sklar J, Zukerberg LR, Harris NL. Nasal lymphoma. A clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol 1991;15:268-279.
68. Maeda H, Aozasa K, Tsujimura T, Sasaki R, Yoshida J, Matsunaga T. Malignant lymphomas and related conditions involving nasal cavity and paranasal sinuses: a clinicopathologic study of forty-two cases with emphasis on prognostic factors. Eur J Surg Oncol 1988;14:9-15.
69. Ho FCS, Choy D, Loke SL, et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol 1990;21:1041-1050.
70. Peiper S. Angiocentric lymphoproliferative disorders of the respiratory system: incrimination of Epstein-Barr virus in pathogenesis. Blood 1993;82:687-690.
71. Braakman E, Sturm E, Vijverberg K, van Krimpen BA, Gratama JW, Bolhuis RLH. Expression of CD45 isoforms by fresh and activated human γδ T-lymphocytes and natural killer cells. Int Immunol 1991;3:691-697.
72. Weiss LM, Picker LJ, Grogan TM, Warnke RA, Sklar J. Absence of clonal beta and gamma T-cell receptor gene rearrangements in a subset of peripheral T-cell lymphomas. Am J Pathol 1988;130:436-442.
73. Medeiros I-J, Peiper SC, Elwood L, et al. Angiocentric immunoproliferative lesions: a molecular analysis of eight cases. Hum Pathol 1991;22:1150-1157.
74. Yamaguchi M, Ohno T, Oka K, et al. Discordant reaction of Leu4 and rabbit anti-human CD3ε in sinonasal lymphoma. Int J Hematol 1993;59:25-30.
75. Suzumiya J, Takeshita M, Kimura N, et al. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood 1994;83:2255-2260.
76. Ohno T, Yamaguchi M, Oka K, Miwa H, Kita K, Shirakawa S. Frequent expression of CD3ε in CD3 (Leu 4)-negative nasal T-cell lymphomas. Leukemia 1995;9: 44-52.
77. Tao Q, Ho FCS, Loke SL, Srivastava G. Epstein-Barr virus is localized in the tumor cells of nasal lymphomas of NK, T or B cell type. Int J Cancer 1 995;60;315-320.
78. Winther B, Innes DJ, Mills SE, Mygind N, Zito D, Hayden FG. Lymphocyte subsets in normal airway mucosa of the human nose. Arch Otolaryngol Head Neck Surg 1987;113:59-62.
79. Salmeron A, Sanchez-Madrid F, Ursa MA, Fresno M, Alarcon B. A conformational epitope expressed upon association of CD3-δ with either CD3-δ or CD3-γ is the main target for recognition by anti-CD3 monoclonal antibodies. J Immunol 1991;147;3047-3052.
80. Soler J, Bordes R, Ortuno F, et al. Aggressive natural killer cell leukemia/lymphoma in two patients with lethal midline granuloma. Br J Haematol 1994;86:659-662.
81. Vilde J-L, Perronne G, Huchon A, et al. Association of Epstein-Barr virus with lethal midline granuloma. N Engl J Med 1985;313:1161.
82. Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990;335:128-130.
83. Ho FCS, Srivastava G, Loke SL, et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type. Hematol Oncol 1990;8:271-281.
84. Weiss LM, Gaffey MJ, Chen Y-Y, Frierson HF Jr. Frequency of Epstein-Barr viral DNA in 'Western' sinonasal and Waldeyer's ring non-Hodgkin's lymphomas. Am J Surg Pathol 1992;16:156-162.
85. Kanavaros P, Lescs M-L, Briere J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993;81:2688-2695.
86. Borisch B, Hennig I, Laeng RH, Waelti ER, Kraft R, Laissue J. Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood 1993;82:858-864.
87. de Bruin PC, Jiwa M, Oudejans JJ, et al. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood 1994;83:1612-1618.
88. Tomita Y, Ohsawa M, Mishiro Y, et al. The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino-nasal region from the Osaka and Okinawa districts of Japan. Lab Invest 1995;73: 190-196.
89. Ng C-S, Chan JKC, Cheng PNM, Szeto S-C. Nasal T-cell lymphoma associated with hemophagocytic lymphoma. Cancer 1986;58:67-71.
90. Falini B, Pileri S, De Solas I, et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 1990;75:434-444.
91. Yao M, Gheng A-N, Su I-J, et al. Clinicopathological spectrum of hemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma. Br J Haematol 1994;87:535-543.
92. Lipford EH, Margolick JB, Longo DL, Fauci AS, Jaffe ES. Angiocentric immunoproliferative lesions: a clinico-pathologic spectrum of post-thymic T-cell proliferations. Blood 1988;72:1674-1681.
93. Liang R, Todd D, Chan TK, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 1995;13:666-670.
94. Ichikawa M, Kawai H, Komiyama A, et al. Functional p75 interleukin-2 receptor expression on the fresh blast cells in childhood acute lymphoblastic leukemia with natural killer cell properties. Am J Hematol 1991;36:259-264.
95. Komiyama A, Kawai H, Miyagawa Y, Akabane T. Childhood lymphoblastic leukemia with natural killer activity: establishment of the leukemia cell lines retaining the activity. Blood 1982;60:1429-1436.
96. Komiyama A, Yamada S, Kawai H, Miyagawa Y, Akabane T. Childhood acute lymphoblastic leukemia with natural killer activity. Clinical and cellular features of three cases. Cancer 1984;54:1547-1553.
97. Kaplan J, Ravindranath Y, Inoue S. T-cell acute lymphoblastic leukemia with natural killer cell phenotype. Am J Hematol 1986;22:355-364.
98. Falcao RP, Ismael SJ. Leu 7+, Leu 1la-acute T-lymphoblastic leukemia having low K cell activity and no NK cell activity. Am J Hematol 1987;24:101-105.
99. Gupta S, Fernandes G. Natural killing and antibody-dependent cytotoxiciiy by T leukemic blasts from acute lymphoblastic leukemia. Scand J Immunol 1982;16:477-480.
100. Pirruccello S, Bicak MS, Gordon BG, Gajl-Peczaalska K, Gnarra DJ, Coccia PF. Acute lymphoblastic leukemia of NK-cell lineage: Response to 1L-2. Leukemia Res 1989;13:735-743.
101. Brody JP, Allen S, Schulman P, et al. Acute agranular CD4-positive natural killer cell leukemia. Cancer 1995;75:2474-2483.
102. Dunphy GH, Gregowicz M, Rodriguez G. Natural killer cell acute leukemia with myeloid antigen expression. A previously undescribed form of acute leukemia. Am J Clin Pathol 1995;104:212-215.
103. Phillips JH, Le AM, Lanier LL. Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and classs Il histocompatibility antigens. J Exp Med 1984;159: 993-1008.
104. Fernandes G, Garrett T, Nair M, Straus D, Good RA, Gupta S. Studies in acute leukemia. I. Antibody-dependent and spontaneous cellular cytotoxicity by leukemic blasts from patients with acute nonlymphoid leukemia. Blood 1979;54:573-580.
105. Hokland P, Hokland M, Ellegarrd J. Malignant monoblasts can function as effector cells in natural killer cell and antibody-dependent cellular cytotoxicity assays. Blood 1981;57:972-974.
106. Vidriales MB, Orfao A, Gonzalez M, et al. Expression of NK and lymphoid associated antigens in blast cells of acute myeloblastic leukemia. Leukemia 1993;7: 2026-2029.
107. - myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood 1994;84:244-255.
108. Warzynski MJ, White C, Golightly MG, et al. Natural killer lymphocyte blast crisis of chronic myelogenous leukemia. Am J Hematol 1989;32:279-286.